Adding Tomosynthesis to Mammography Reduces Recall Rate

This article originally appeared here.
Share this content:
Addition of Tomosynthesis to Mammography Cuts Recall Rate
Addition of Tomosynthesis to Mammography Cuts Recall Rate

(HealthDay News) -- For patients presenting for screening mammography, the addition of tomosynthesis is associated with reduced recall rates for all breast densities and patient ages, according to a study published online July 30 in Radiology.

Brian M. Haas, M.D., from the Yale University School of Medicine in New Haven, Conn., and colleagues compared the screening recall and cancer detection rates for tomosynthesis plus conventional digital mammography versus mammography alone in a cohort of 13,158 patients who presented for screening mammography at four clinical sites. Of the patients, 6,100 underwent tomosynthesis in addition to conventional mammography.

The researchers found that the overall recall rate was significantly lower for patients in the tomosynthesis group versus the conventional mammography alone group (8.4 versus 12.0 percent). For all breast densities and patient age groups, the addition of tomosynthesis reduced recall rates. Significant differences were noted for scattered fibroglandular, heterogeneously dense, and extremely dense breasts, and for patients aged younger than 40, 40 to 49, 50 to 59, and 60 to 69 years. After adjustment for age, breast density, and increased breast cancer risk, the findings persisted. There was no significant difference in the cancer detection rate for tomosynthesis versus conventional mammography alone (5.7 versus 5.2 per 1,000 patients; P = 0.70).

"In summary, in our study we found that breast tomosynthesis reduces screening mammography recall rates, particularly for younger women and women with dense breasts, without significant changes in cancer detection," the authors write.

Two authors disclosed financial ties to Hologic.

Full Text (subscription or payment may be required)

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs